Detalhe da pesquisa
1.
Retraction Note: miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2.
Nature
; 582(7810): 134, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32483375
2.
Author Correction: miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2.
Nature
; 570(7761): E51, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31127195
3.
EphA2- and HDAC-Targeted Combination Therapy in Endometrial Cancer.
Int J Mol Sci
; 25(2)2024 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38279277
4.
Broad-acting therapeutic effects of miR-29b-chitosan on hypertension and diabetic complications.
Mol Ther
; 30(11): 3462-3476, 2022 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35965413
5.
Combination of EphA2- and Wee1-Targeted Therapies in Endometrial Cancer.
Int J Mol Sci
; 24(4)2023 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36835335
6.
MEK inhibition overcomes resistance to EphA2-targeted therapy in uterine cancer.
Gynecol Oncol
; 163(1): 181-190, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34391578
7.
Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancers.
Genome Res
; 27(7): 1112-1125, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28411194
8.
miR-34a blocks osteoporosis and bone metastasis by inhibiting osteoclastogenesis and Tgif2.
Nature
; 512(7515): 431-5, 2014 Aug 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-25043055
9.
RNA interference-based therapy and its delivery systems.
Cancer Metastasis Rev
; 37(1): 107-124, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29243000
10.
Activating p53 family member TAp63: A novel therapeutic strategy for targeting p53-altered tumors.
Cancer
; 125(14): 2409-2422, 2019 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31012964
11.
Peroxisomes contribute to oxidative stress in neurons during doxorubicin-based chemotherapy.
Mol Cell Neurosci
; 86: 65-71, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29180229
12.
Yes-associated protein 1 and transcriptional coactivator with PDZ-binding motif activate the mammalian target of rapamycin complex 1 pathway by regulating amino acid transporters in hepatocellular carcinoma.
Hepatology
; 63(1): 159-72, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26389641
13.
Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer.
Mol Syst Biol
; 10: 728, 2014 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-24799285
14.
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma.
Nat Med
; 12(8): 939-44, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16862152
15.
Enhancing oral delivery of plant-derived vesicles for colitis.
J Control Release
; 357: 472-483, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37031740
16.
Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5L.
Nat Commun
; 14(1): 2407, 2023 04 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37100807
17.
Effects of simulated microgravity on expression profile of microRNA in human lymphoblastoid cells.
J Biol Chem
; 286(37): 32483-90, 2011 Sep 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-21775437
18.
Targeting CCR2+ macrophages with BET inhibitor overcomes adaptive resistance to anti-VEGF therapy in ovarian cancer.
J Cancer Res Clin Oncol
; 148(4): 803-821, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35094142
19.
Molecular Analysis of Short- versus Long-Term Survivors of High-Grade Serous Ovarian Carcinoma.
Cancers (Basel)
; 14(17)2022 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36077735
20.
Assessment of In Vivo siRNA Delivery in Cancer Mouse Models.
Methods Mol Biol
; 2372: 157-168, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34417750